11β‐Hydroxysteroid dehydrogenase expression and activity in the human adrenal cortex
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Although oxidation of Cortisol or corticosterone by 11β‐hydroxysteroid dehydrogenase (11β‐HSD) represents the physiological mechanism conferring specificity for aldosterone on the mineralocorticoid receptor in mineralocorticoid target tissues, little attention has been paid until now to the expression and activity of this enzyme in human adrenals. We have shown that human adrenal cortex expresses 11β‐HSD type 2 (11β‐HSD2) gene, and found a marked 11β‐HSD2 activity in microsomal preparations obtained from slices of decapsulated normal human adrenal cortices. Under basal conditions, adrenal slices secreted, in addition to cortisol and corticosterone (B), sizeable amounts of cortisone and 11‐dehydrocorticosterone (DH‐B), the inactive forms to which the former glucocorticoids are converted by 11β‐HSD. Addition of the 11β‐HSD inhibitor glycyrrhetinic acid elicited a moderate rise in the production of cortisol and B and suppressed that of cortisone and DH‐B. ACTH and angiotensin II evoked a marked rise in the secretion of cortisol and B, but unexpectedly depressed the release of cortisone and DH‐B. ACTH also lowered the capacity of adrenal slices to convert [ 3 H]cortisol to [ 3 H]cortisone. This last effect of ACTH was concentration‐dependently abolished by both aminoglutethimide and cyanoketone, which blocks early steps of steroid synthesis, but not by metyrapone, an inhibitor of 11β‐hydroxylase. Collectively, these findings indicate that the human adrenal cortex possesses an active 11β‐HSD2 engaged in the inactivation of newly formed glucocorticoids. The activity of this enzyme is negatively modulated by the main agonists of glucocorticoid secretion through an indirect mechanism, probably involving the rise in the intra‐adrenal concentration of non‐11β‐hydroxylated steroid hormones.—Mazzocchi, G., Rossi, G. P., Neri, G., Malendowicz, L. K., Albertin, G., Nussdorfer, G. G. 11β‐Hydroxysteroid dehydrogenase expression and activity in the human adrenal cortex. FASEB J. 12, 1533–1539 (1998)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of the acute production of steroids in steroidogenic cells
STOCCO, D. M., & CLARK, B. J. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-3-221 · Cited by 1,057
A new isoform of 11 beta-hydroxysteroid dehydrogenase in aldosterone target cells
Rusvai, E., & Náray-Fejes-Tóth, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82044-0 · Cited by 248
Localization of 11beta-hydroxysteroid dehydrogenase type 2 in rat tissues: in situ studies.
Roland, B. L., & Funder, J. W. (1996) · Endocrinology · doi:10.1210/endo.137.3.8603583 · Cited by 88
Lebrethon, M. C., Jaillard, C., Defayes, G., Begeot, M., & Saez, J. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.5.8175981 · Cited by 51
Cited by
Swart, A. C., Schloms, L., Storbeck, K.-H., Bloem, L. M., Toit, T. D., Quanson, J. L., Rainey, W. E., & Swart, P. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.04.010 · Cited by 125
The effects of ACTH on steroid metabolomic profiles in human adrenal cells
Xing, Y., Edwards, M. A., Ahlem, C., Kennedy, M., Cohen, A., Gomez-Sanchez, C. E., & Rainey, W. E. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0493 · Cited by 101
Coulter, C. L., Smith, R. E., Stowasser, M., Sasano, H., Krozowski, Z. S., & Gordon, R. D. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00077-5 · Cited by 27
Metadata
- Authors
- Mazzocchi, G., Rossi, G. P., Neri, G., Malendowicz, L. K., Albertin, G., & Nussdorfer, G. G.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1998-11
- Volume
- 12
- Issue
- 14
- Pages
- 1533-1539
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1543083586
- Cited by
- 57
- References
- 4
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.